Others’ studies have also shown that Crabp1 expression is reduced in MN disease models, such as spinal muscular atrophy and amyotrophic lateral sclerosis (ALS) [13–15]. This evidence concerns the gene CRABP1 and amyotrophic lateral sclerosis.